Navigation Links
2011 CTRC-AACR San Antonio Breast Cancer Symposium to focus on new treatments and prevention
Date:12/1/2011

SAN ANTONIO Now in its 34th year, the 2011 CTRC-AACR San Antonio Breast Cancer Symposium will focus on emerging treatments in hard-to-treat populations, including patients with metastatic breast cancer, and on new knowledge about prevention and risk.

The symposium will be held at the Henry B. Gonzales Convention Center in San Antonio during Dec. 6-10, 2011.

The symposium is presented by the Cancer Therapy & Research Center at University of Texas Health Science Center at San Antonio, the American Association for Cancer Research and Baylor College of Medicine. The driving force behind this collaboration is the shared mission of the organizations to advance progress in breast cancer research.

To help guide coverage for the news media, the AACR Office of Communications will operate a full-service press room in Room 217A-C of the convention center.

New research will be presented during the following five press conferences held in Room 217D. Reporters who cannot attend in person can call in using the following information:

  • U.S./Canada (Toll Free): 1 (888) 647-7462
  • International (Toll): 1 (201) 604-0169

The meeting will open with a press conference on Wednesday, Dec. 7, 2011, at 7:30 a.m. CT, hosted by Jennifer Ligibel, M.D., a breast oncologist and assistant professor of medicine at the Dana-Farber Cancer Institute. The press conference will focus on the following research:

  • Diabetes and Obesity Increase Risk for Breast Cancer Development
  • Molecular Differences May Be Used to Predict Early vs. Late Hormone Receptor-Positive Breast Cancer Recurrence
  • Brachytherapy Was Associated With Twofold Increased Risk for Mastectomy, Complications
  • New Test Predicts Risk for Recurrence for Patients With DCIS

Later that afternoon, at 12:30 p.m. CT, the Institute of Medicine will present a report entitled, "Breast Cancer and the Environment: A Life Course Approach." More information can be found here.

Finally, at 5:00 p.m. CT, James Ingle, M.D., professor of oncology at the Mayo Clinic in Rochester, will host a media availability on important new research in bisphosphonates and breast cancer, which will feature the following research:

  • Zoledronic Acid Shows Long-Term Benefit in Survivorship for Premenopausal ER-Positive Breast Cancer
  • Clodronate Appeared Safe, Modestly Affected Breast Cancer Disease Events
  • Immediate Bisphosphonate Use With Endocrine Therapy Reduced Recurrence, Increased Survival in Postmenopausal Early Breast Cancer
  • Oral Bisphosphonate Did Not Improve Prognosis for Patients With Breast Cancer

On Thursday, Dec. 8, 2011, at 7:30 a.m. CT, Lisa A. Carey, M.D., Preyer distinguished professor in breast cancer research at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, will host a press conference featuring late-stage clinical trials in hard-to-treat populations. The press conference will feature the following research:

  • Dual HER2 Blockade Significantly Extends Progression-Free Survival
  • Exemestane Plus Everolimus Increased Progression-Free Survival for Women With Metastatic Breast Cancer
  • Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer

At 12:30 p.m. CT, on Thursday, Dec. 8, 2011, Patricia Ganz, M.D., professor at the UCLA Schools of Medicine and Public Health and director of the division of cancer prevention and control research at the Jonsson Comprehensive Cancer Center, will host a press conference on issues in genetics and socioeconomics that will feature the following research:

  • Risk for Developing New Cancer in Other Breast Increased for Survivors With BRCA Mutation
  • Many Women Do Not Undergo Breast Reconstruction After Mastectomy
  • Bilateral Oophorectomy Associated With Higher Prevalence of Low Bone Mineral Density and Arthritis in Younger Women

In addition to the press conferences, the 2011 CTRC-AACR San Antonio Breast Cancer Symposium has identified the following research as newsworthy:

  • Starch Intake May Influence Risk for Breast Cancer Recurrence
  • Intermittent, Low-Carbohydrate Diets More Successful Than Standard Dieting, Present Possible Intervention for Breast Cancer Prevention
  • Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients
  • MRI May Be Noninvasive Method to Measure Breast Cancer Prognosis
  • Obesity Linked to Worse Outcomes in Early Breast Cancer Treatment
  • Breast Cancer Mortality Higher in Hispanic Women


'/>"/>

Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Cancer research presented at 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium
2. San Antonio Business Journal Names BMI of Texas One of the Best Places to Work in San Antonio
3. BMI of Texas Offers Free Educational Seminars in San Antonio for People Considering Weight Loss Surgery
4. San Antonio Chamber Honors Women Business, Community Leaders
5. VA Announces $41 Million in Construction Contracts for San Antonio
6. First whole-genome sequencing clinical trials for triple-negative breast cancer presented
7. Lobular Breast Cancer Linked to Paternal Cancer History
8. Gene acts as a brake on breast cancer progression
9. New study shows biopsy of recurrent breast cancer can alter treatment
10. Older Women Have More Post-Surgical Breast Reduction Infections
11. Breast cancer type linked to paternal cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... 2017 , ... On Saturday, October 21, the Health & Wellness Center at ... raise money for the American Heart Association Heart Walk. Teams of up to 10 ... to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical (AVACEN) ... is now successfully helping those with the widespread pain ... Fibromyalgia diagnosed Amanda in Essex, England ... washing my hair, experiencing no sleep at all, tremendous ... spasm… I cannot recommend [the AVACEN 100] enough, how ...
Breaking Medicine Technology: